胆红素吸附治疗慢性重型乙型肝炎的效果及安全性评估

汪清海; 罗开忠; 田沂

doi:10.3969/j.issn.1001-5256.2016.07.016

胆红素吸附治疗慢性重型乙型肝炎的效果及安全性评估

DOI: 10.3969/j.issn.1001-5256.2016.07.016

1. 常德市第一人民医院感染科
2. 中南大学湘雅二医院肝病研究中心

基金项目:

湖南省卫生厅科研基金资助课题(B2006-052)；

详细信息

中图分类号: R512.62
计量
- 文章访问数: 2222
- HTML全文浏览量: 5
- PDF下载量: 449
- 被引次数: 0
出版历程
- 出版日期: 2016-07-20

Effect and safety of bilirubin serum adsorption in treatment of patients with chronic severe hepatitis B

Research funding:

摘要

摘要: 目的评估慢性重型乙型肝炎患者胆红素吸附的疗效及安全性。方法前瞻性研究2014年1月1日-2015年12月31日于中南大学湘雅二医院住院的凝血酶原活动度（PTA）>25%的慢性重型乙型肝炎患者40例,均予胆红素吸附治疗。收集治疗前后以及治疗后一周的患者血常规[白细胞（WBC）、红细胞、血红蛋白、血小板],凝血功能[凝血酶原时间（PT）、活化部分凝血活酶时间（APTT）、纤维蛋白原（Fib）],肝功能[TBil、DBil、总胆汁酸（TBA）、白蛋白（Alb）、球蛋白（Glb）]、电解质(K+、Na+、Cl-、Ca2+),治疗前后和治疗过程中观察记录患者血压、呼吸、心率、氧饱和度,观察患者有无畏寒发热、头晕、胸闷、腹痛等症状。计量资料组间比较采用t检验。结果患者对治疗的耐受性均较好,治疗结束后患者临床症状好转。TBil、DBil、TBA均下降,Alb、Glb、Fib亦有轻度下降,而PT、APTT则较治疗前延长,差异均具统计学意义（t值分别为21.254、22.395、7.821、6.986、7.58...
- 肝炎,乙型,慢性 /
- 胆红素 /
- 治疗
Abstract: Objective To investigate the effect and safety of bilirubin serum adsorption( BSA) in the treatment of patients with chronic severe hepatitis B. Methods A prospective study was performed for 40 patients with chronic severe hepatitis B[prothrombin activity( PTA)> 25%] who were hospitalized in The Second Xiangya Hospital of Central South University from January 1,2014 to December 31,2015,and all the patients were given BSA. The results of routine blood test [white blood cell( WBC) count,red blood cell( RBC) count,hemoglobin( Hb),and platelet( PLT) count],coagulation function [prothrombin time( PT),activated partial thromboplastin time( APTT),and fibrinogen( Fib) ],liver function [total bilirubin( TBil),direct bilirubin( DBil),total bile acid( TBA),albumin( Alb),and globulin( Glb) ],and electrolytes( K+,Na+,Cl-,and Ca2+) were collected before treatment and at 1 week after treatment. Blood pressure,breath,heart rate,and oxygen saturation were observed and recorded before,during,and after treatment,and the presence or absence of symptoms such as fear of cold,pyrexia,dizziness,chest distress,and abdominal pain was observed. The t- test was used for comparison of continuous data between groups. Results All the patients had good tolerance of the treatment,and clinical symptoms were improved after treatment. TBil,DBil,and TBA showed significant reductions,Alb,Glb,and Fib showed slight reductions,and PT and APTT were significantly prolonged( t = 21. 254,22. 395,7. 821,6. 986,7. 580,9. 852,10. 705,and 5. 528,all P < 0. 001). After treatment,Ca2+level was significantly reduced and WBC count increased significantly( t = 6. 924 and 9. 852,both P < 0. 001). At the 1- week follow- up,Alb,Glb,Fib,PT,APTT,Ca2+level,and WBC count almost returned to the same levels before treatment,and TBil,DBil,and TBA showed varying degrees of increases compared with the values after treatment,but remained lower than the values before treatment. Of all the40 patients,12( 30%) experienced adverse events,among whom 3( 7. 5%) experienced fear of cold( or chills),3( 7. 5%) experienced reduced blood pressure,2( 5. 0%) experienced reduced heart rate,1( 2. 5%) experienced nausea and vomit,1( 2. 5%) experienced abdominal pain,and 1( 2. 5%) experienced cold sweat. Conclusion BSA therapy is safe and effective in the treatment of patients with chronic severe hepatitis B and PTA > 25% and has transient effects on patients' coagulation function,serum calcium,and WBC count.
- hepatitis B /
- chronic /
- bilirubin

HTML全文

参考文献(13)

[1]WAN YM,YANG LH,YANG JH,et al.The effect of plasma exchange on entecavir-treated chronic hepatitis B patients with hepatic de-compensation and acute-on-chronic liver failure[J].Hepatol Int,2016,10(3):462-469.

[2]KARVELLAS CJ,STRAVITZ RT.High volume plasma exchange in acute liver failure:dmpening the inflammatory cascade?[J].J Hepatol,2016,64(1):10-12.

[3]KUANG YL,YUAN WJ,ZHANG Z,et al.Effects of non-bioartificial liver support system on Gc-globulin in patients with liver failure[J].Chin J Hepatol,2011,19(3):196-200.(in Chinese)邝永玲,袁伟杰,张政,等.人工肝支持系统对肝移植围手术期肝衰竭患者Gc球蛋白的影响[J].中华肝脏病杂志,2011,19(3):196-200.

[4]TSIPOTIS E,SHUJA A,JABER BL.Albumin dialysis for liver failure:a systematic review[J].Adv Chronic Kidney Dis,2015,22(5):382-390.

[5]DUAN ZP.Hemoperfusion adsorption and supporting from artificial liver[J].Chin J Hepatol,2003,11(8):503.(in Chinese)段钟平.血液灌流吸附与人工肝脏支持[J].中华肝脏病杂志,2003,11(8):503.

[6]DUAN ZP,CHEN Y.Rencent progress and future perspectives of liver failure diagnosis and treatment strategies[J].J Clin Hepatol,2012,28(10):721-725.(in Chinese)段钟平,陈煜.肝衰竭诊疗:进展与展望[J].临床肝胆病杂志,2012,28(10):721-725.

[7]Chinese Society of Hepatology,Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B(2010 version)[J].Chin J Hepatol,2011,19(1):13-24.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版)[J].中华肝脏病杂志,2011,19(1):13-24.

[8]SENF R,KLINGEL R,KURZ S,et al.Bilirubin-adsorption in23 critically ill patients with liver failure[J].Int J Artif Organs,2004,27(8):717-722.

[9]WU SH,GAN JH,HUANG XP,et al.Clinical effect of albumin dialysis combined with plasma perfusion in treatment of liver failure[J].J Clin Hepatol,2014,30(5):434-437.(in Chinese)吴绍宏,甘建和,黄小平,等.白蛋白透析联合血浆灌流治疗肝衰竭的临床观察[J].临床肝胆病杂志,2014,30(5):434-437.

[10]MAGGI U,NITA G,GATTI S,et al.Hyperbilirubinemia after liver transplantation:the role of coupled plasma filtration adsorption[J].Transplant Proc,2013,45(7):2715-2717.

[11]YE XL,CHENG SQ.The research progress of non-bioartificial liver support system and its combination use in liver failure therapy[J/CD].Chin J Clinicians:Electronic Edition,2014,8(11):2150-2155.(in Chinese)叶晓玲,程书权.非生物型人工肝及其联合应用的研究进展[J/CD].中华临床医师杂志:电子版,2014,8(11):2150-2155.

[12]DUAN ZW,DENG Y,WU YP.Effect of an adsorption system of bilirubin adsorption column combined with disposable hemoperfutor for hyperbilirubinemia[J].China Med Herald,2014,11(26):21-25.(in Chinese)段志文,邓龑,武杨屏.胆红素吸附柱联合血液灌流器的吸附系统治疗高胆红素血症的效果[J].中国医药导报,2014,11(26):21-25.

[13]ZHOU PQ,ZHENG SP,YU M,et al.Prognosis of acute-on-chronic liver failure patients treated with artificial liver support system[J].World J Gastroenterol,2015,21(32):9614-9622.

施引文献

资源附件(0)

访问统计